The Spanish infection control market is projected to grow at a compound annual growth rate of 7.46% over the forecast period to attain a market size of US$671.272 million in 2027, from US$405.726 million in 2020. Spain is regarded as a global leader in organ transplants, therefore due to the high volume of transplant surgeries there, the market is anticipated to grow rapidly. with high growth in the forecast period. Also, the presence of health centres and clinics in Spain further adds to increased market growth in the forecast period. The presence of good healthcare facilities for women and children is poised to drive the growth of the infection control market for these population groups in the forecast period.
Moreover, the number of positive coronavirus cases in the country is also increasing rapidly. Hence, it becomes necessary for the market to thrive to provide maximum protection to health workers and patients. Such epidemic and pandemic situations allow the market to grow at a high growth rate projected to be at its peak during that period.
A high organ transplantation rate is estimated to increase the growth of the infection control market in the forecast period.
Spain is considered the world leader in organ donation; hence, with a high rate of organ transplantation surgeries conducted yearly, the demand for reducing surgical site infections during transplantation is propagating the market growth in the forecast period. According to the National Transplant Organization Statistics, in 2017, Spain attained an exceptional record of 46.9 donors per million, accounting for 2183 donors. The number of donors is estimated to surge by around 30% in the last three years. According to the organization's statistics, around six individuals donated organs daily, while 14 transplants were estimated to be performed daily. This has further led to the performing performance of 5,259 organ transplants, surpassing a figure of around 5000 transplants for the first time, beating its own record. As per the data, the country has achieved a new record of 2,183 total donors (as mentioned earlier), and in the case of solid organ transplants, it was recorded as 5261 donors. There were 3269 kidney transplants performed in the same year, 1247 liver transplants, 304 heart transplants, 363 lung transplants, 70 pancreas transplants, and eight intestinal transplants took place. Also, it was observed that the waiting list for all organs was reduced except for the pancreas.
The exclusive healthcare facilities for women will further augment the market growth in the forecast period.
The healthcare facilities for women in Spain are normally good, but the facilities are more readily available in the urban environment. The availability of gynaecologists for pregnant women where most of the births occur in a hospital setting is projected to surge and drive market growth with the immense requirement for infection control during childbirth. Also, with the provision of legal abortions in the country, the market is further estimated to grow significantly in the forecast period. However, termination of a pregnancy is allowed under specific circumstances only, for example, in the case of a serious health risk to the life of the unborn or the mother’s health.
Key Development:
COVID-19 SCENARIO
The need for sterilisation and disinfection in hospitals and clinics has increased during COVID-19. There have also been technological advances in sterilisation and disinfection equipment, a surge in the outsourcing of sterilisation services by hospitals, pharmaceutical, and medical device companies, and an increase in the production of single-use products and medical nonwovens. The COVID-19 outbreak has caused a sharp rise in demand for infection control products, which has significantly impacted the expansion of the infection control market in Spain. The market for infection control is likely to rise, but it will be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed devices. On the other hand, during the forecast period, increased use of single-use medical nonwovens and devices is anticipated to present profitable prospects.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2020 | US$405.726 million |
| Market Size Value in 2027 | US$671.272 million |
| Growth Rate | CAGR of 7.46% from 2020 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2022–2027 |
| Forecast Unit (Value) | USD Million |
| Segments Covered | Product And End User Industry |
| Companies Covered | 3M, Medtronic, STERIS plc, B. Braun Melsungen AG, Getinge AB |
| Customization Scope | Free report customization with purchase |
Segmentation